Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.3
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Pre-funded warrants
Common Stock
Pre-funded warrants
Additional Paid-In Capital
Pre-funded warrants
Preferred Stock
Series E-2 Preferred Stock
Preferred Stock
Series E-3 preferred stock
Preferred Stock
Series E-4 preferred stock
Preferred Stock
Common Stock
Series E-2 Preferred Stock
Common Stock
Series E-3 preferred stock
Common Stock
Series E-4 preferred stock
Common Stock
Additional Paid-In Capital
Series E-2 Preferred Stock
Additional Paid-In Capital
Series E-3 preferred stock
Additional Paid-In Capital
Series E-4 preferred stock
Additional Paid-In Capital
Accumulated Deficit
Series D preferred stock
Series E-4 preferred stock
Total
Balance beginning at Dec. 31, 2023             $ 4,677,632       $ 7       $ 182,924,410 $ (202,761,017)     $ (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023             319.76       691,470                
Balance beginning Series D preferred stock at Dec. 31, 2023                                 $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                                 111.11    
Stock-based compensation                             454,363       454,363
Conversion of preferred stock into common stock $ 1 $ 3,972,539 $ 3,972,540 $ (1,203,346) $ (33,983,571)       $ 3     $ 1,203,346 $ 33,983,568            
Conversion of preferred stock into common stock (in shares) 35,971     82.26 (1,575)     30,132 329,670                    
Exercise of warrants for preferred stock, net of issuance costs             $ 47,577,000                       47,577,000
Exercise of warrants for preferred stock, net of issuance costs (in shares)             2,205                        
Exercise of warrants for common stock                             2,298,143       2,298,143
Exercise of warrants for common stock (in shares)                     18,239                
Net loss                               (26,641,983)     (26,641,983)
Balance ending Series D preferred stock at Mar. 31, 2024                                 $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Mar. 31, 2024                                 111.11    
Balance ending at Mar. 31, 2024             $ 17,067,715       $ 11       224,836,369 (229,403,000)     12,501,095
Balance ending (in shares) at Mar. 31, 2024             867.5       1,105,482                
Balance beginning at Dec. 31, 2023             $ 4,677,632       $ 7       182,924,410 (202,761,017)     (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023             319.76       691,470                
Balance beginning Series D preferred stock at Dec. 31, 2023                                 $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                                 111.11    
Net loss                                     (42,226,073)
Balance ending Series D preferred stock at Sep. 30, 2024                                 $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Sep. 30, 2024                                 111.11    
Balance ending at Sep. 30, 2024             $ 13,615,544       $ 13       246,536,473 (244,987,090)     15,164,940
Balance ending (in shares) at Sep. 30, 2024             1,066.1       1,352,218                
Balance beginning at Mar. 31, 2024             $ 17,067,715       $ 11       224,836,369 (229,403,000)     12,501,095
Balance beginning (in shares) at Mar. 31, 2024             867.5       1,105,482                
Balance beginning Series D preferred stock at Mar. 31, 2024                                 $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2024                                 111.11    
Stock-based compensation                             799,249       799,249
Conversion of preferred stock into common stock         $ (9,224,112)       $ 1       $ 9,224,111            
Conversion of preferred stock into common stock (in shares)         (427.5)       89,482                    
Net loss                               (919,371)     (919,371)
Balance ending Series D preferred stock at Jun. 30, 2024                                 $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Jun. 30, 2024                                 111.11    
Balance ending at Jun. 30, 2024             $ 7,843,603       $ 12       234,859,729 (230,322,371)     12,380,973
Balance ending (in shares) at Jun. 30, 2024             440       1,194,964                
Stock-based compensation                             1,534,054       1,534,054
Issuance of preferred stock, net of issuance costs           $ 15,914,632                       $ 15,914,632  
Issuance of preferred stock, net of issuance costs (in shares)           1,610                          
Conversion of warrants into common shares       $ (1,285,851)   $ (8,856,840)       $ 1   $ 1,285,851   $ 8,856,839          
Conversion of warrants into common shares (in shares)       (87.9)   (896)   32,198   125,030                  
Stock option exercise into common stock (in shares)                     26                
Net loss                               (14,664,719)     (14,664,719)
Balance ending Series D preferred stock at Sep. 30, 2024                                 $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Sep. 30, 2024                                 111.11    
Balance ending at Sep. 30, 2024             $ 13,615,544       $ 13       246,536,473 (244,987,090)     15,164,940
Balance ending (in shares) at Sep. 30, 2024             1,066.1       1,352,218                
Balance beginning at Dec. 31, 2024             $ 520,778       $ 15       261,116,351 (247,342,463)     14,294,681
Balance beginning (in shares) at Dec. 31, 2024             35.6       1,535,996                
Balance beginning Series D preferred stock at Dec. 31, 2024                                 $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2024                                 111.11    
Stock-based compensation                             562,737       562,737
Net loss                               (6,604,029)     (6,604,029)
Balance ending Series D preferred stock at Mar. 31, 2025                                 $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Mar. 31, 2025                                 111.11    
Balance ending at Mar. 31, 2025             $ 520,778       $ 15       261,679,088 (253,946,492)     8,253,389
Balance ending (in shares) at Mar. 31, 2025             35.6       1,535,996                
Balance beginning at Dec. 31, 2024             $ 520,778       $ 15       261,116,351 (247,342,463)     14,294,681
Balance beginning (in shares) at Dec. 31, 2024             35.6       1,535,996                
Balance beginning Series D preferred stock at Dec. 31, 2024                                 $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2024                                 111.11    
Net loss                                     (16,495,816)
Balance ending Series D preferred stock at Sep. 30, 2025                                 $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Sep. 30, 2025                                 111.11    
Balance ending at Sep. 30, 2025             $ 520,778       $ 32       271,314,776 (263,838,280)     7,997,306
Balance ending (in shares) at Sep. 30, 2025             35.6       3,192,040                
Balance beginning at Mar. 31, 2025             $ 520,778       $ 15       261,679,088 (253,946,492)     8,253,389
Balance beginning (in shares) at Mar. 31, 2025             35.6       1,535,996                
Balance beginning Series D preferred stock at Mar. 31, 2025                                 $ 1,382,023    
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2025                                 111.11    
Stock-based compensation                             565,391       565,391
Exercise of warrants for common stock                     $ 3       2,714,140       2,714,143
Exercise of warrants for common stock (in shares)                     276,044                
Net loss                               (5,447,911)     (5,447,911)
Balance ending Series D preferred stock at Jun. 30, 2025                                 $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Jun. 30, 2025                                 111.11    
Balance ending at Jun. 30, 2025             $ 520,778       $ 18       264,958,619 (259,394,403)     6,085,012
Balance ending (in shares) at Jun. 30, 2025             35.6       1,812,040                
Stock-based compensation                             567,788       567,788
Issuance of common stock and pre-funded warrants, net of issuance costs                     $ 11       5,788,369       5,788,380
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)                     1,045,000                
Exercise of warrants for common stock                     $ 3               3
Exercise of warrants for common stock (in shares)                     335,000                
Net loss                               (4,443,877)     (4,443,877)
Balance ending Series D preferred stock at Sep. 30, 2025                                 $ 1,382,023    
Balance ending Series D preferred stock (in shares) at Sep. 30, 2025                                 111.11    
Balance ending at Sep. 30, 2025             $ 520,778       $ 32       $ 271,314,776 $ (263,838,280)     $ 7,997,306
Balance ending (in shares) at Sep. 30, 2025             35.6       3,192,040